Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Nextech3D.ai Announces First New Customer Win For its AI Powered Photography Studio (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

Healthcare Biotechnology
ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational... see more

NDAQ:PMN - Post Discussion

ProMIS Neurosciences Inc > sage advice
View:
Post by M101 on Jan 17, 2025 4:36pm

sage advice

I would love to know what our major investors are thinking about Sage suing Biogen today (I don't have the details). Is this why they want total control or are they already acting on behalf of some big pharma player? 
Thoughts? 

https://www.biopharmadive.com/news/biogen-sage-acquisition-deal-offer-wall-street/737141/
Comment by G1945V on Jan 18, 2025 5:49am
M101, can you please connect the dots so I know if and how this saga (between Biogen and Sage) may or may not relate to PMN if this is where you are going?  G1945V
Comment by M101 on Jan 18, 2025 11:24am
Sage is a Boston are pharma with a CNS focused drug platform including a couple of approved depression drugs. They were in a development agreement with Biogen which is about to end, and now Biogen has made a hostile takeover bid. From Sage website: "**Biogen terminated its rights as to the SAGE-324 program in September 2024; the termination will be effective on February 17, 2025 ...more  
ProMIS Neurosciences Inc